Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2003
08/14/2003US20030152574 Modulate nucleic acid gene expression
08/14/2003US20030152566 Soluble CD40L (CD154) as a prognostic marker of atherosclerotic diseases
08/14/2003CA2483630A1 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations
08/14/2003CA2476214A1 Proliferated cell lines and uses thereof
08/14/2003CA2475767A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds
08/14/2003CA2475637A1 Quinolinone derivatives for treating cell proliferation related disorders
08/14/2003CA2475247A1 Anti-pathogen treatments
08/14/2003CA2475101A1 Recombinant bovine immunodeficiency virus based gene transfer system
08/14/2003CA2475093A1 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent
08/14/2003CA2474974A1 Cytoprotective benzofuran derivatives
08/14/2003CA2474917A1 Granzyme b inhibitors
08/14/2003CA2474884A1 Stimulation of cpt-1 as a means to reduce weight
08/14/2003CA2474748A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/14/2003CA2474687A1 N-allyloxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use of thereof as medicaments
08/14/2003CA2474533A1 Novel 3-aryl-2,5-dihydroxy-1,4-benzoquinone derivatives, their preparation method and pharmaceutical compositions containing same
08/14/2003CA2474283A1 Amino acid sequences capable of facilitating penetration across a biological barrier
08/14/2003CA2474214A1 Novel aryl- and heteroarylpiperazines
08/14/2003CA2474203A1 Compositions and methods for promoting lipid mobilization, glycogen mobilization, or both, in humans
08/14/2003CA2474186A1 Compositions and methods for restoring immune responsiveness in patients with immunological defects
08/14/2003CA2474168A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/14/2003CA2473499A1 Minrs as modifiers of insulin receptor signaling and methods of use
08/14/2003CA2473459A1 Pyridineamido derivatives as inhibitors of monoamine oxidase (mao-b)
08/14/2003CA2473182A1 Compositions and methods for treatment of vitamin d deficiency
08/14/2003CA2473181A1 Quinoline derivatives as npy antagonists
08/14/2003CA2466251A1 Therapeutic use of aziridino compounds
08/13/2003EP1334973A1 Preventive or therapeutic medicines for diabetes containing fused-heterocycle compounds or their salts
08/13/2003EP1334721A1 Nateglinide-containing hydrophilic drug preparations
08/13/2003EP1334720A1 Nateglinide-containing preparations
08/13/2003EP1334719A2 Pentafluorobenzenesulfonamides and analogs
08/13/2003EP1334194A2 Imaging, diagnosis and treatment of disease
08/13/2003EP1334186A2 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications
08/13/2003EP1334180A1 Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fatty liver in lipid biosynthesis
08/13/2003EP1334102A1 Bombesin receptor antagonists
08/13/2003EP1334100A1 Bombesin receptor antagonists
08/13/2003EP1334094A1 Cholesterol lowering benzo[b]thiophenes and benzo[d]isothiazoles
08/13/2003EP1333887A2 Combination therapy comprising anti-diabetic and anticonvulsant agents
08/13/2003EP1333846A1 Preparation and xenotransplantation or porcine islets
08/13/2003EP1333841A2 M. tuberculosis chaperonin 10 and uses thereof
08/13/2003EP1333840A2 M. tuberculosis chaperonin 60.1 and uses thereof
08/13/2003EP1333838A2 Compounds comprising a phytosterol and/or phytostanol moiety and ascorbic acid and use thereof as weight regulating agents
08/13/2003EP1333834A2 Antiinflammation agents
08/13/2003EP1333833A2 Novel compounds
08/13/2003EP1333827A2 Estrogen receptor modulators
08/13/2003EP1333821A2 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists
08/13/2003EP1333816A2 Medicine based on anti-hyperglycaemic microcapsules with prolonged release and method for preparing same
08/13/2003EP1333809A2 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
08/13/2003EP1333808A2 Electroprocessed composition used in drug delivery and cell encapsulation
08/13/2003EP1333719A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
08/13/2003EP1222193B1 Imidazole derivatives as phosphodiesterase vii inhibitors
08/13/2003EP1148793B1 Method of preparing microparticles of phytosterols or phytostanols
08/13/2003EP1140943B1 Substituted pyrroloindoles
08/13/2003EP0879233B1 Chinoline and benzimidazole derivatives as bradykinin agonists
08/13/2003EP0751774B1 Hypocholesterolemic mercaptoacetylamide disulfide derivatives
08/13/2003EP0614374B1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES
08/13/2003CN1436239A Novel enzyme gene and its expression product
08/13/2003CN1436235A Anti-angiogenic polypeptides
08/13/2003CN1436192A HMG-CoA reductase inhibitors and method
08/13/2003CN1436185A Thrombin receptor antagonists
08/13/2003CN1436174A HMG-CoA reductase inhibitors and their use as medicaments for treatment of cholesterol related diseases
08/13/2003CN1436170A Vitamin D derivs.
08/13/2003CN1436047A Compositions and methods for improving vascular health
08/13/2003CN1435418A Aromatic nitrogen-contg. bis-phosphonic acid derivs., process for preparing same and use thereof
08/13/2003CN1435255A Hypoglycemic medicine contg. slime bacteria sporocarp and preparing process thereof
08/13/2003CN1435249A Chinese patent medicine for treating hyperlipidemia and fatty liver and preparing process thereof
08/13/2003CN1435211A Formulation of compound snail mixture and preparing process thereof
08/13/2003CN1435209A Medicine for treating biabetes and preparing process thereof
08/13/2003CN1435203A Hypoglycemic lozemge and producing method thereof
08/13/2003CN1435180A Gypenoside drip pill, and preparing process thereof
08/13/2003CN1117573C Protein iron microelement complement agent and its producing method
08/13/2003CN1117571C Improved calcium dietary supplement
08/13/2003CN1117567C Paroxetine controlled release compositions
08/13/2003CN1117566C Combination therapy comprising amlodipine and statin compound
08/13/2003CN1117562C Compositions and method for controlling smoking
08/13/2003CN1117561C Compounded calcium preparation, preparing method and use thereof
08/12/2003US6605753 Transgenic mouse with increased insulin sensitivity; resistance to weight gain when fed a high fat, high carbohydrate diet
08/12/2003US6605729 Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)
08/12/2003US6605642 Inhibitors of formation of advanced glycation endproducts (AGES)
08/12/2003US6605641 20-HETE antagonists and agonists
08/12/2003US6605640 Treating a retinal or choroidal vascular or hereditary disease by topically administering an acetylcholine esterase inhibitor, e.g., Phospholine Iodide; age related macular degeneration disease; diabetic retinopathy
08/12/2003US6605639 Treating and/or preventing diseases alleviated by retinoid X receptor ligand dependent transcriptional regulation using ascochlorin or derivatives
08/12/2003US6605636 Atorvastatin hemi-calcium form VII
08/12/2003US6605634 Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents
08/12/2003US6605632 Affinity for melatonin receptors
08/12/2003US6605612 Cardioprotective phosohonates and malonates
08/12/2003US6605610 Aryl fused azapolycyclic compounds
08/12/2003US6605603 Uses of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acid
08/12/2003US6605601 Hypotensive agents; cardiovascular disorders
08/12/2003US6605600 Diuretics
08/12/2003US6605597 Partial or full A1agonists-N-6 heterocyclic 5′-thio substituted adenosine derivatives
08/12/2003US6605310 Calorically dense liquid oral supplement
08/12/2003US6605270 Iron-binding polymers for oral administration
08/12/2003CA2212836C Substituted isoxazoles for the treatment of inflammation
08/08/2003WO2002060922A2 Epoxyvibsanin b
08/08/2003CA2458220A1 Epoxyvibsanin b
08/07/2003WO2003065036A1 Method of identifying insulin secretion stimulating compounds, and the use of such compounds in treating insulin-secretion related disorders
08/07/2003WO2003064629A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003WO2003064596A2 Desaturase genes, enzymes encoded thereby, and uses thereof
08/07/2003WO2003064467A1 A complex of a human foxc2 protein and a foxc2-interacting protein
08/07/2003WO2003064451A2 MODULATION OF TYPE IIβ PHOSPHOINOSITIDE PHOSPHATE KINASE
08/07/2003WO2003064444A1 Fractionation of phytosterol esters in oil
1 ... 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 ... 1298